| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Verrica Pharmaceuticals Inc (NASDAQ: VRCA)
VRCA Technical Analysis
3
| As on 25th Jul 2025 VRCA SHARE Price closed @ 6.61 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.47 & Buy for SHORT-TERM with Stoploss of 5.71 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VRCASHARE Price
| Open | 5.86 | Change | Price | % |
| High | 6.78 | 1 Day | 5.91 | 844.29 |
| Low | 5.86 | 1 Week | 5.77 | 686.90 |
| Close | 6.61 | 1 Month | 5.99 | 966.13 |
| Volume | 133790 | 1 Year | 1.25 | 23.32 |
| 52 Week High 9.56 | 52 Week Low 0.41 | ||||
NASDAQ USA Most Active Stocks
| HCTI | 0.07 | 40.00% |
| AMRS | 0.14 | 100.00% |
| NCNA | 0.06 | 20.00% |
| LIDR | 4.43 | 51.71% |
| INTC | 20.70 | -8.53% |
| OPEN | 2.54 | 4.96% |
| ESSA | 635.00 | 2981.03% |
| TSLA | 316.06 | 3.52% |
| NVDA | 173.50 | -0.14% |
| LMDX | 0.02 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VRCA Daily Charts |
VRCA Intraday Charts |
Whats New @ Bazaartrend |
VRCA Free Analysis |
|
|
VRCA Important Levels Intraday
| RESISTANCE | 8.38 |
| RESISTANCE | 7.81 |
| RESISTANCE | 7.46 |
| RESISTANCE | 7.11 |
| SUPPORT | 6.11 |
| SUPPORT | 5.76 |
| SUPPORT | 5.41 |
| SUPPORT | 4.84 |
VRCA Forecast July 2025
| 4th UP Forecast | 11.85 |
| 3rd UP Forecast | 10.17 |
| 2nd UP Forecast | 9.13 |
| 1st UP Forecast | 8.09 |
| 1st DOWN Forecast | 5.13 |
| 2nd DOWN Forecast | 4.09 |
| 3rd DOWN Forecast | 3.05 |
| 4th DOWN Forecast | 1.37 |
VRCA Weekly Forecast
| 4th UP Forecast | 8.52 |
| 3rd UP Forecast | 7.91 |
| 2nd UP Forecast | 7.53 |
| 1st UP Forecast | 7.15 |
| 1st DOWN Forecast | 6.07 |
| 2nd DOWN Forecast | 5.69 |
| 3rd DOWN Forecast | 5.31 |
| 4th DOWN Forecast | 4.70 |
VRCA Forecast2025
| 4th UP Forecast | 27.85 |
| 3rd UP Forecast | 21.04 |
| 2nd UP Forecast | 16.83 |
| 1st UP Forecast | 12.62 |
| 1st DOWN Forecast | 0.6 |
| 2nd DOWN Forecast | -3.61 |
| 3rd DOWN Forecast | -7.82 |
| 4th DOWN Forecast | -14.63 |
Verrica Pharmaceuticals Inc ( NASDAQ USA Symbol : VRCA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VRCA Business Profile
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; which has completed phase II clinical trial for treating common warts; and that is in phase II clinical trial for the treatment of external genital warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania. Address: 44 West Gay Street, West Chester, PA, United States, 19380
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service